<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genome Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Genome Res</journal-id>
<journal-id journal-id-type="hwp">genome</journal-id>
<journal-id journal-id-type="pmc">genome</journal-id>
<journal-id journal-id-type="publisher-id">GENOME</journal-id>
<journal-title-group>
<journal-title>Genome Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">1088-9051</issn>
<issn pub-type="epub">1549-5469</issn>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31227601</article-id>
<article-id pub-id-type="pmc">6633265</article-id>
<article-id pub-id-type="medline">9509184</article-id>
<article-id pub-id-type="doi">10.1101/gr.239756.118</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Exome-wide assessment of the functional impact and pathogenicity of multinucleotide mutations</article-title>
<alt-title alt-title-type="left-running">Kaplanis et al.</alt-title>
<alt-title alt-title-type="right-running">Pathogenicity of multinucleotide mutations</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-1142-6683</contrib-id>
<name>
<surname>Kaplanis</surname>
<given-names>Joanna</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akawi</surname>
<given-names>Nadia</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gallone</surname>
<given-names>Giuseppe</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McRae</surname>
<given-names>Jeremy F.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Prigmore</surname>
<given-names>Elena</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wright</surname>
<given-names>Caroline F.</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fitzpatrick</surname>
<given-names>David R.</given-names>
</name>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Firth</surname>
<given-names>Helen V.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barrett</surname>
<given-names>Jeffrey C.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hurles</surname>
<given-names>Matthew E.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<collab>on behalf of the Deciphering Developmental Disorders study</collab>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label>Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1SA, United Kingdom;</aff>
<aff id="af2"><label>2</label>Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DU, United Kingdom;</aff>
<aff id="af3"><label>3</label>Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, EX2 5DW, United Kingdom;</aff>
<aff id="af4"><label>4</label>MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, United Kingdom;</aff>
<aff id="af5"><label>5</label>Department of Clinical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, United Kingdom</aff>
<author-notes>
<corresp>Corresponding author: <email>meh@sanger.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<month>7</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="ppub"/>. -->
<volume>29</volume>
<issue>7</issue>
<fpage>1047</fpage>
<lpage>1056</lpage>
<history>
<date date-type="received">
<day>22</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>5</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>
<ext-link ext-link-type="uri" xlink:href="http://genome.cshlp.org/site/misc/terms.xhtml">© 2019 Kaplanis et al.; Published by Cold Spring Harbor Laboratory Press</ext-link>
</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This article, published in <italic>Genome Research</italic>, is available under a Creative Commons License (Attribution 4.0 International), as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="1047.pdf"></self-uri>
<abstract>
<p>Approximately 2% of de novo single-nucleotide variants (SNVs) appear as part of clustered mutations that create multinucleotide variants (MNVs). MNVs are an important source of genomic variability as they are more likely to alter an encoded protein than a SNV, which has important implications in disease as well as evolution. Previous studies of MNVs have focused on their mutational origins and have not systematically evaluated their functional impact and contribution to disease. We identified 69,940 MNVs and 91 de novo MNVs in 6688 exome-sequenced parent–offspring trios from the Deciphering Developmental Disorders Study comprising families with severe developmental disorders. We replicated the previously described MNV mutational signatures associated with DNA polymerase zeta, an error-prone translesion polymerase, and the APOBEC family of DNA deaminases. We estimate the simultaneous MNV germline mutation rate to be 1.78 × 10<sup>−10</sup> mutations per base pair per generation. We found that most MNVs within a single codon create a missense change that could not have been created by a SNV. MNV-induced missense changes were, on average, more physicochemically divergent, were more depleted in highly constrained genes (pLI ≥ 0.9), and were under stronger purifying selection compared with SNV-induced missense changes. We found that de novo MNVs were significantly enriched in genes previously associated with developmental disorders in affected children. This shows that MNVs can be more damaging than SNVs even when both induce missense changes, and are an important variant type to consider in relation to human disease.</p>
</abstract>
<funding-group>
<award-group id="funding-1">
<funding-source>Health Innovation Challenge Fund</funding-source>
<award-id>HICF-1009-003</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>Wellcome Sanger Institute</funding-source>
<award-id>WT098051</award-id>
</award-group>
<award-group id="funding-3">
<funding-source>UK Department of Health</funding-source>
</award-group>
<award-group id="funding-4">
<funding-source>UK Research Ethics Committee</funding-source>
<award-id>10/H0305/83</award-id>
</award-group>
<award-group id="funding-5">
<funding-source>Cambridge South Research Ethics Committee</funding-source>
<award-id>GEN/284/12</award-id>
</award-group>
<award-group id="funding-6">
<funding-source>Republic of Ireland Research Ethics Committee</funding-source>
</award-group>
<award-group id="funding-7">
<funding-source>National Institutes for Health Research</funding-source>
</award-group>
<award-group id="funding-8">
<funding-source>Sanger Human Genome Informatics team</funding-source>
</award-group>
<award-group id="funding-9">
<funding-source>Sample Management team</funding-source>
</award-group>
<award-group id="funding-10">
<funding-source>Illumina High-Throughput team</funding-source>
</award-group>
<award-group id="funding-11">
<funding-source>New Pipeline Group team</funding-source>
</award-group>
<award-group id="funding-12">
<funding-source>DNA pipelines team</funding-source>
</award-group>
<award-group id="funding-13">
<funding-source>Core Sequencing team</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>